Given below is the list of accepted abstracts. The next step for the presenting authors is to prepare a 10-minute video presentation as per the guidelines. Ensure to download and use the provided PowerPoint template to create your slides.
Congratulations and best wishes for the progress ahead.
Last date to submit Video Presentation for Selected Abstracts
Sunday, Sep 13th, 2026
Ph.D. | Post Doc. | Industry
| Sr | Abstract Title |
|---|---|
| P01 | A Dual-Loaded Transferosomal System with Compartment-Specific Dermal Drug Delivery for Management of Cutaneous Melanoma |
| P02 | A mucoadhesive zein-trimethylchitosan nanocarrier for oral diacerein delivery: Formulation, Optimization, Ex vivo intestinal permeation and In vivo evaluation |
| P03 | A QbD driven Penetration-Enhanced Hydrogel Patch of Gandhapura Patra Taila: Matrix-Controlled Diffusion Kinetics via Factorial Design |
| P04 | An Ionic Liquid-Based Ionogel for Synergistic Atorvastatin and Sorafenib Therapy in Melanoma |
| P05 | Beyond Conventional Oils: Target Product Profile-Driven Tunable Ionic Liquid Formulations for Enhanced Oral Delivery of Niclosamide |
| P06 | Biomimetic Skin Lipid-Based Nanoparticles for Enhanced Cutaneous Drug Localization in Psoriasis: From Release Kinetics to Dermatokinetic and Preclinical Evaluation |
| P07 | Brimonidine tartrate and Brinzolamide co-loaded W/O polymeric emulsion nanofiber for Glaucoma treatment |
| P08 | Comparative Evaluation of Carbohydrate-based Dissolving Microneedles for Improved Permeation and Skin Deposition of Model Hydrophilic Drug |
| P09 | Delamanid-Loaded PLGA Nanoparticles through QbD-Engineering: Relationship between Solid State Modification, Dissolution Enhancement and Antimycobacterial Activity Against MDR/XDR Tuberculosis |
| P10 | Development and characterization of lipid-based formulation for improved delivery of drug discovery lead against tuberculosis. |
| P11 | Development and Evaluation of a Hyaluronic Acid–Imiquimod Niosomal Gel for Sustained Drug Release and Enhanced Skin Permeation |
| P12 | Development and evaluation of Captisol®-based inclusion complex of bedaquiline fumarate for enhancing its solubility and bioavailability |
| P13 | Development and In Vitro Drug Release Evaluation of Hyaluronic Acid-Conjugated Erlotinib–Fisetin Lipid–Polymer Hybrid Nanoparticles for Targeted Triple-Negative Breast Cancer Therapy |
| P14 | Development and In-Vitro Evaluation of a Novel Herbal Nanoemulsion for Rapid Sublingual Delivery in Dysmenorrhea |
| P15 | Development and Optimization of a Transferrin-Targeted Thermosensitive In Situ Gel for Enhanced In Vitro Release and Permeation in Localized Cervical Cancer Therapy |
| P16 | Development of a Metformin-Loaded Implantable Electrospun Nanofiber Scaffold for Spinal Cord Injury Treatment: In Vitro Sustained Release Evaluation and Preliminary Type IV Dissolution Method Development |
| P17 | Dissolution Enhancement of a Poorly Soluble EGFR Inhibitor and Phytoconstituent in Combination Using Electrospun Nanofiber Mat for Oral Cancer Therapy |
| P18 | Dissolution Enhancement of Voriconazole and Study of Drug Release Profiles of Voriconazole Pessaries |
| P19 | DPI Delivery of Trojan Microparticulates Encapsulating Doxorubicin for Lung Cancer Therapy |
| P20 | Effect of Crystal Habit on In-Muscle Aggregation and Release Kinetics from a Long-Acting Micro-suspension Injection of Bedaquiline |
| P21 | ENHANCEMENT OF AQUEOUS SOLUBILITY AND RHEOLOGICAL CHARACTERIZATION OF CURCUMIN USING NON-IONIC SURFACTANTS AND CO-SOLVENTS |
| P22 | Enhancement of Dissolution and Oral Bioavailability of Bedaquiline Fumarate Using Cyclodextrin Inclusion Complexes |
| P23 | Fabrication of APTES Functionalized Mesoporous Silica Nanoparticles Coated with Mannosylated Chitosan for Tunable Adsorption and pH Controlled Release of Syringic Acid |
| P24 | From Apparent Solubility to Molecular Drug Availability: A QbD Driven Strategy for Enhanced Dissolution and Intestinal Permeation |
| P25 | FROM DISSOLUTION KINETICS TO TUMOR REGRESSION: MECHANISTIC BASIS FOR DRUG-SPECIFIC ECM-MODULATION SYNERGY IN PEGYLATED STEALTH LIPOSOMAL TKI DELIVERY FOR NSCLC |
| P26 | From Excipient Innovation to Drug Release: Improving Sofosbuvir Dissolution Using a Novel Spray-Dried Co-Processed Excipient |
| P27 | Impact of dose/solubility ratio in gastric fluid on pH-shift dissolution-permeation behavior of weakly basic BCS II drugs: Role of drug-polymer physical mixtures and amorphous solid dispersions |
| P28 | Implementation of convolution method of IVIVC for predicting in-vivo Pharmacokinetics of Rivaroxaban |
| P29 | In Vitro Dissolution and Release Kinetics of Edaravone-Loaded Nanofiber Scaffolds for Bone Regeneration |
| P30 | In vitro drug release studies from cell membrane coated PLGA nanoparticles for the treatment of solid tumour |
| P31 | Mesoporous Silica Nanoparticles for Sustained Release and Enhanced Pharmacokinetic-Pharmacodynamic Performance of Galantamine Hydrobromide |
| P32 | Nano to Skin: Unlocking Curcumin Release from a Sliver Nanoparticles-Loaded Emulgel |
| P33 | Niosomal Gel Delivery of Tacrolimus for Psoriasis: A DOE-Based Formulation Study |
| P34 | Nutraceutical and Probiotic-Based Strategies to Enhance the Oral Bioavailability of Quercetin and Naringin: A Comparative Pharmacokinetic Evaluation in Rats |
| P35 | Palmitic acid incorporation enhances Diclofenac Sodium skin permeation from Albumin-based gels |
| P36 | Personalized 3D Printed Rice Starch-Based Vegan Gummies: A Child-Friendly Platform with Appealing Sensory Attributes and Facile Drug Release |
| P37 | Polyherbal Cubosomal gel for enhanced topical delivery: design, optimization by central composite design, in vitro and ex-vivo evaluation |
| P38 | Quality-by-Design Enabled Self-Nanoemulsifying Drug Delivery System for Ferulic Acid: Integration of Dissolution Profiling, Pharmacokinetics and PBPK Modelling for Enhanced Oral Bioavailability |
| P39 | Redesigning Nanostructured Lipid Carriers: Ionic Liquid Integration for Improved Drug Loading and Oral Delivery of Cabazitaxel in Triple-negative Breast Cancer |
| P40 | Thermoresponsive intranasal pterostilbene-loaded nanoemulgel enhances nose-to-brain delivery and neuroprotection in experimental ischemic stroke |
M.Pharm | Masters | Pharm D.
| Sr | Abstract Title |
|---|---|
| M01 | Advanced comparative evaluation of thymoquinone-loaded ethosomal hydrogel using real-time in-vitro release monitoring and microfluidic ex-vivo skin permeation |
| M02 | Cocrystal Engineering as a Regulatory-Recognized Strategy for Solubility and Dissolution Enhancement of Genistein: A Genistein-Caffeic Acid Pharmaceutical Cocrystal System |
| M03 | Colon-Targeted Folate-Conjugated Chitosan Microspheres: A Dissolution-Optimized Delivery System for Repositioning of Mebendazole in Colorectal Cancer. |
| M04 | Comparative In Vitro Drug Release and Ex Vivo Permeation Assessment of a Nanoparticle-Based Vaginal Drug Delivery System |
| M05 | Cyclodextrin inclusion complexation: an effective approach for the enhancing the soubility and dissolution profile of morin hydrate |
| M06 | Design and Characterization of Azithromycin Loaded Pectin–Hyaluronic Acid Nano Hydrogel for the Treatment of Skin Infections |
| M07 | Design and evaluation of nanoparticulated orodispersible films of tramadol hydrochloride for effective pain management |
| M08 | Design, Characterization and In-vivo Evaluation of Lipid Carriers loaded with Protease Inhibitors for neuro AIDS therapy |
| M09 | Development and evaluation of a self micro emulsifying drug delivery system of brexpiprazole |
| M10 | Development and Evaluation of a Trans-Anethole-Loaded Nanoemulgel for Enhanced Topical Delivery and Anti-Psoriatic Efficacy |
| M11 | Development and evaluation of niacinamide loaded ginger derived nanovesicular gel |
| M12 | Development and In Vitro Dissolution Evaluation of a Bilayer Lansoprazole–Metronidazole Tablet Using a pH-Shift Dissolution Approach for Helicobacter pylori Therapy |
| M13 | Development and In Vitro Dissolution Profiling of a Polyherbal Sustained-Release Matrix Tablet for Effective Management of Diabetes Mellitus |
| M14 | Development and In-Vitro Evaluation of an Effervescent Polyherbal Floating Drug Delivery System Containing DGL and Mastic Gum for Sustained Gastroprotective Action |
| M15 | Development and Optimization of Solid Dispersion-Loaded Cubosomes in Lyophilized Porous Tablets for Enhanced Dissolution of Lornoxicam |
| M16 | Development and Preclinical Evaluation of Resveratrol-Loaded Lipomeric Thermosensitive Gel for Accelerated Wound Healing via Modulation of Pro-Inflammatory Cytokines |
| M17 | Development and Validation of a Dissolution Method for Olanzapine Immediate-release Tablet using HPLC |
| M18 | Development and validation of an automated adaptive machine learning platform for spectrophotometric quantification and in vitro release monitoring of herbal compounds by evaluation of multiple regression algorithms and automatic selection of the optimal predictive model. |
| M19 | Development of a Novel in vitro simulation model for Dissolution testing of the sipping spout drug delivery system. |
| M20 | Development of budesonide-loaded nanoparticles for colon targeted drug delivery system by using ph-sensitive polymers |
| M21 | Development of Graphene Oxide Nanoparticle Hydrogel for Topical Delivery of Tofacitinib: In Vitro Release and Ex Vivo Permeation Evaluation |
| M22 | Development of polymeric nano sponges for enhancing the dissolution of poorly water-soluble drug |
| M23 | Development, Optimization, and Characterization of Thymoquinone and Resveratrol Co-Loaded Niosomal Hydrogel for the Treatment of Psoriasis |
| M24 | Dissolution Profiling and Release Kinetics of a Novel Spray-Dried Oral Nutraceutical Powder for Targeted IBD Management |
| M25 | Dual-Trigger pH sensitive Mesoporous Silica–β-Cyclodextrin Hybrid Carriers: A Synergistic Nanoconfinement–Host/Guest Strategy for Dissolution Enhancement of Cabazitaxel for Prostate Cancer |
| M26 | Enhanced In-Vitro Release of a Poorly Soluble Flavonoid Glycoside from a Quality-by-Design-Optimized Phytosomal Capsule: A Comparative Study against a Conventional Dosage Form |
| M27 | Enhancement of skin permeation and diffusion by novel emulgel formulation for psoriasis |
| M28 | Enhancement of solubility and dissolution profile of apremilast using cyclodextrin-based inclusion complexation |
| M29 | Evaluation of site-selective release of ropinirole hydrochloride SLN incorporated nasal in-situ gel |
| M30 | Exploring the Potential of Oral Etodolac CAGE Ionic-Liquid Based SNEDDS for Effective Management of Rheumatoid Arthritis |
| M31 | Film forming topical sprays of bifonazole – design and in-vitro release studies |
| M32 | Formulation and Evaluation of Buccal Films of Enalapril Using Natural Mucoadhesive Polymer Chitosan |
| M33 | Formulation and evaluation of calotropis-based emulgel for pain relief |
| M34 | Formulation and evaluation of polymeric micelles loaded in situ ophthalmic gel of celecoxib. |
| M35 | Formulation evaluation of loronoxicam -curcumin co-loaded self nanoemulsifying drug delivery systems |
| M36 | Formulation, Development and In Vitro Dissolution Assessment of a Pulsatile Delivery System of Vildagliptin for Type 2 Diabetes Mellitus |
| M37 | From Minitablets to MUPS: Development of a Multiparticulate Vonoprazan Platform for Enhanced Oral Therapy |
| M38 | In Vitro Evaluation of Lopinavir-Loaded Nanostructured Lipid Carrier Capsules for Enhanced Oral Bioavailability |
| M39 | In Vitro Permeation Evaluation of Drug X-Loaded Dissolving Microneedles for Nose-to-Brain Delivery |
| M40 | In Vitro Release and Ex Vivo Skin Permeation of an Essential Oil-Based Film-Forming Spray for Sustained Topical Delivery in Dysmenorrhea |
| M41 | In vitro release and ex vivo transdermal permeation kinetics of dual-drug polymeric micelle-incorporated dissolving microneedle patches |
| M42 | Intranasal delivery of Resveratrol loaded Solid lipid nanoparticles based In-situ gel for the management of Alzheimer’s disease |
| M43 | Intranasal thermo-responsive in-situ gel of nebivolol and curcumin-loaded cationic nanoliposomes for cardiovascular targeting |
| M44 | In-vitro and In-vivo Dissolution Efficacy Study of pH Modulated Delivery of Curcumin SLN-Microspheres for the Management of Inflammatory Bowel Disease |
| M45 | In-vitro release kinetics of polymeric micelle-based dry powder inhaler of vilanterol trifenatate and resveratrol |
| M46 | Nanoengineered Cubic Lipid Carriers of Abiraterone Acetate for Enhanced Dissolution and Oral Bioavailability |
| M47 | Optimizing Sorbitol-Based Pore Former Levels for Zero-Order Release in Gastro-Retentive Controlled Porosity Osmotic Pump Systems |
| M48 | PEGylated Carboxylated Multi-walled Carbon Nanotubes for Nose-to-Brain Delivery of Rivastigmine Tartrate in Alzheimer’s Disease |
| M49 | pH-Programmed Dissolution of a Dual-Drug Pediatric Gummy: 2³ Factorial Screening and In Vitro Release of Ondansetron Hydrochloride and Folic Acid |
| M50 | Quality by Design–Optimized Rutin-Loaded Transferosomal Film-Forming Gel for Enhanced Transdermal Delivery in the Management of Varicose Veins |
| M51 | Rational Diffusion-Guided Design of Anise Oil-Loaded Topical Nanoemulgel for Sustained Anti-inflammatory Delivery in Rheumatoid Arthritis |
| M52 | Soft Wearable Electroresponsive 3D-Printed Films with Built-In Piezoelectrically Driven Self-Powering for Programmable Drug Release |
| M53 | Technique-Dependent Polymer Selection for High-Loading Amorphous Solid Dispersions of Albendazole: Biopredictive Non-Sink Dissolution, Supersaturation Maintenance & Accelerated Stability |
| M54 | Thermo responsive mucoadhesive nasal gels of rasagiline tartrate – development and in vitro release studies |